Remove Consulting Remove Patients Remove Pharmacology
article thumbnail

Angion stock falls after agreeing Elicio Therapeutics merger

pharmaphorum

The AMP technology was developed by the laboratories of Darrell Irvine, professor of biomedical engineering in the Koch Institute of Integrative Cancer Research at MIT, who is a co-founder of Elicio, as well as serving as a consultant to the company and head of its scientific advisory board.

article thumbnail

3D Medical Animation: Transforming Healthcare Communication with Precision and Clarity

Infuse Medical

Companies in 3D medical animation such as Infuse Med are adept in converting complicated medical jargon into understandable images appealing to patients, doctors, and other stakeholders. Check out some case studies where 3D medical animation simplified communication between healthcare professionals and their patients.

Medical 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

10 There is a fear that such practices discourage innovative approaches, impacting on patient welfare. He is now an independent GMC consultant. Patent Protection of Pharmacologically Active Metabolites: Theoretical and Technological Analysis on the Jurisprudence of Four Regions. About the author. CN202010111235.3A. 2020-02-24.

article thumbnail

Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms

pharmaphorum

Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. More approvals, in larger patient population conditions will elevate the ongoing discussion of how to pay for these therapies.

FDA 98
article thumbnail

The 5 Best Pharmaceutical Sales Training Programs

MedReps

As a result, doctors can make treatment decisions in their patients’ best interests. Consultative Selling. At the heart of any solid pharmaceutical sales training program is consultative selling or the act of solving problems for your customer. Sprint Prospecting. Let’s face it.

article thumbnail

Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain

Legacy MEDSearch

Senza HFX iQ is the first and only Artificial Intelligence-based SCS system that learns from patients. It was developed to address the variability in pain from patient to patient and to help patients optimize and maintain long-term pain relief and improved quality of life. Keith Grossman, Chairman and CEO of Nevro.

FDA 52
article thumbnail

Strategies for Streamlining Small Molecule Formulation Development When Bridging from Candidate Selection to First-in-Human Clinical Testing

Pharmaceutical Technology

At Quotient Sciences, our drug development consultants use our 30+ years of experience in clinical research outcomes to profile each new molecule that we look at. This approach to candidate development demonstrably reduces the overall time and cost of getting new medicines to patients in need.